Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania

A. J. Breugom, E. Bastiaannet, P. G. Boelens, E. Van Eycken, L. H. Iversen, A. Martling, R. Johansson, T. Evans, S. Lawton, K. M. O'Brien, H. Ortiz, R. Janciauskiene, O. M. Dekkers, H. J. T. Rutten, G. J. Liefers, V. E. P. P. Lemmens, C. J. H. van de Velde*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1338-1343
Number of pages6
JournalEuropean Journal of Surgical Oncology
Volume44
Issue number9
DOIs
Publication statusPublished - Sep 2018

Keywords

  • Rectal cancer
  • International comparison
  • Population-based
  • Stage I-III
  • Surgery
  • Oncologic treatment
  • TOTAL MESORECTAL EXCISION
  • PREOPERATIVE RADIOTHERAPY
  • ADJUVANT CHEMOTHERAPY
  • POSTOPERATIVE CHEMOTHERAPY
  • OPEN-LABEL
  • FOLLOW-UP
  • OXALIPLATIN
  • TRIAL
  • CHEMORADIOTHERAPY
  • FLUOROURACIL

Cite this

Breugom, A. J., Bastiaannet, E., Boelens, P. G., Van Eycken, E., Iversen, L. H., Martling, A., Johansson, R., Evans, T., Lawton, S., O'Brien, K. M., Ortiz, H., Janciauskiene, R., Dekkers, O. M., Rutten, H. J. T., Liefers, G. J., Lemmens, V. E. P. P., & van de Velde, C. J. H. (2018). Oncologic treatment strategies and relative survival of patients with stage I-III rectal cancer - A EURECCA international comparison between the Netherlands, Belgium, Denmark, Sweden, England, Ireland, Spain, and Lithuania. European Journal of Surgical Oncology, 44(9), 1338-1343. https://doi.org/10.1016/j.ejso.2018.05.025